Merck & Co., Inc.
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30243% above fair value
$148.36−1.16 (-0.78%)
Close on Nov 2, 2026Market cap $366.03BP/E 118.7Yield 2.21%
Merck Animal Health by Quarter
Animal Health — Companion Animal (vaccines & parasiticides) — Worldwide reported growth YoY (%) (%)
Merck Animal Health: 7.0% in Q2 2026, up 1.0 pts from a year earlier.
Latest, Q2 2026
7.0%
Period ended Jun 30, 2026
Change on a year earlier
+1.0 pts
6.0% in Q2 2025
History
11 quarters
Since Q2 2023
Sources
11
Documents cited below
Where the Q2 2026 figure comes from
“|| Companion Animal | 734 | 685 | 7 | 333 | 309 | 8 | 402 | 376 | 7”
Source: Form 8-K (tm2621496d1_ex99-1.htm, filed 2026-08-04) ↗
Reported in Form 8-K Table 3 / 3a / 3b Product Sales.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Merck Animal Health (%), quarterly Q2 2023–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-ah-companion-ww-nom-yoy
See every metric in the Merck KPI table. Data updated Oct 26, 2026.
See a number that looks wrong?